Myomo (MYO) Current Deferred Revenue (2016 - 2025)
Historic Current Deferred Revenue for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to $134800.0.
- Myomo's Current Deferred Revenue rose 32125.0% to $134800.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $134800.0, marking a year-over-year increase of 32125.0%. This contributed to the annual value of $83115.0 for FY2024, which is 87667.45% up from last year.
- Myomo's Current Deferred Revenue amounted to $134800.0 in Q3 2025, which was up 32125.0% from $108780.0 recorded in Q2 2025.
- Myomo's Current Deferred Revenue's 5-year high stood at $134800.0 during Q3 2025, with a 5-year trough of $900.0 in Q2 2023.
- Moreover, its 5-year median value for Current Deferred Revenue was $10262.5 (2023), whereas its average is $33273.3.
- As far as peak fluctuations go, Myomo's Current Deferred Revenue tumbled by 9451.35% in 2021, and later surged by 148000.0% in 2022.
- Over the past 5 years, Myomo's Current Deferred Revenue (Quarter) stood at $1500.0 in 2021, then skyrocketed by 1313.33% to $21200.0 in 2022, then crashed by 59.86% to $8510.0 in 2023, then skyrocketed by 876.67% to $83115.0 in 2024, then surged by 62.18% to $134800.0 in 2025.
- Its last three reported values are $134800.0 in Q3 2025, $108780.0 for Q2 2025, and $129900.0 during Q1 2025.